Lena-Christin Conradi

8PUBLICATIONS
65CO-AUTHORS
Predictive and prognostic markersMechanobiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 28, 2026
Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.

Alexandra Maria Schmitt, Fabio Bennet Gätje, Michelle Yi Ran Tran

|Jul 15, 2024
Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy.

Marcus Edelmann, Shuang Fan, Tiago De Oliveira

|Mar 11, 2024
Enhancement of colorectal cancer therapy through interruption of the HSF1-HSP90 axis by p53 activation or cell cycle inhibition.

Tamara Isermann, Kim Lucia Schneider, Florian Wegwitz

|Nov 14, 2023
Implications of Rectal Cancer Radiotherapy on the Immune Microenvironment: Allies and Foes to Therapy Resistance and Patients' Outcome.

Dorothée Sartorius, Moritz Leander Blume, Johannes Robert Fleischer

|Jun 02, 2023
CDK4/6 inhibition confers protection of normal gut epithelia against gemcitabine and the active metabolite of irinotecan.

Joshua Blume, Luisa Claus, Tamara Isermann

Pageof 2